Ferrovial and Carlyle have reached an exclusivity agreement to negotiate the transfer to Ferrovial of the 96% of the stake held by Carlyle in the consortium appointed to design, build and operate the new Terminal 1 at Airport JFK (N. York)
Published on 02/18/2022
On corporate transactions: mergers, acquisitions and others
Pursuant to the Consolidated Text of the Spanish Securities Market Act (Texto Refundido de la Ley del Mercado de Valores) and the Regulation (EU) on Market Abuse, Ferrovial, S.A. communicates the following:
INSIDE INFORMATION
Ferrovial and Carlyle have reached an exclusivity agreement to negotiate the transfer to Ferrovial of the 96% of the stake held by Carlyle in New Terminal One, the consortium appointed to design, build and operate the new Terminal 1 at International Airport JFK in New York (which includes de former Terminals 1, 2 and 3 of this airport and possible extensions). Carlyle holds a 51% stake in New Terminal One. If an agreement is reached on the transaction, Ferrovial would therefore acquire a 96% of said stake. The closing of the deal would be subject to the usual conditions for this type of transactions, including the approval of Port Authority of New York and New Jersey.
Madrid, 18 February 2022
Santiago Ortiz Vaamonde
Secretary of the Board of Directors of Ferrovial, S.A.
More information about this Inside Information
English translation for information purposes only. In the event of discrepancies between the English and the Spanish version, the Spanish version shall prevail.
Stock Exchange Filings
Transactions carried out by Ferrovial between 14 and 18 September 2026 under its share repurchase program
22/09/2026- Stock exchange filings
Transactions carried out by Ferrovial between 7 and 11 September 2026 under its share repurchase program
15/09/2026- Stock exchange filings
Ferrovial announces the extension of the duration of its current share repurchase program
14/09/2026- Stock exchange filings
Ferrovial announces effectiveness of the delisting of its ordinary shares from Euronext Amsterdam
11/09/2026- Stock exchange filings